Turning Point Brands (TPB) caught investor attention after reporting first quarter 2026 results and raising full year earnings guidance, including higher Modern Oral gross and net sales expectations for the year.
See our latest analysis for Turning Point Brands.
Despite the raised 2026 earnings guidance and recent Q1 update, the share price is down 19.14% year to date and 32.79% over three months. At the same time, the 1-year total shareholder return of 21.89% and very large 3-year total shareholder return of around 3x suggest longer term momentum has been strong.
If you are looking beyond tobacco and accessories, this could be a moment to broaden your watchlist with 18 top founder-led companies
So, with earnings guidance raised, Modern Oral targets set higher, and the stock trading at a reported 46% discount to the average analyst price target of US$130, is TPB genuinely undervalued right now, or is it already pricing in future growth?
Most Popular Narrative: 33% Undervalued
With Turning Point Brands last closing at $89.14 against a narrative fair value of $132.50, the gap is wide enough that the underlying story matters a lot.
The expanding route to market strategy, including a major increase in sales force headcount and the rollout of leading DTC brands like ALP into brick and mortar retail, leverages shifts in consumer purchasing to alternative channels, supporting broader distribution, incremental revenue, and improved operational efficiency.
Want to see what is baked into that valuation gap? The narrative focuses on changes in revenue growth, shifting margins, and an earnings multiple that is described as richer than usual.
Result: Fair Value of $132.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the story could change quickly if Modern Oral growth disappoints or if regulatory action on nicotine pouches tightens and puts pressure on revenue and margins.
Find out about the key risks to this Turning Point Brands narrative.
Another View: Rich P/E Despite Fair Ratio
Analysts see Turning Point Brands trading at a P/E of 31.1x, compared with 12.6x for the global Tobacco industry and 29.3x for peers. Yet the fair ratio is 32.2x, which is close. That leaves a higher priced stock, but not wildly out of line. How comfortable are you with that trade off?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With mixed signals on valuation, growth, and sentiment, it makes sense to move quickly, test the assumptions yourself, and weigh both sides using 3 key rewards and 1 important warning sign
Ready to hunt for more ideas?
If you stop with just one stock, you might miss other opportunities entirely. Use the screeners below to pressure test and expand your watchlist.
- Target resilience first and filter for companies that prioritise capital preservation through a 65 resilient stocks with low risk scores.
- Zero in on potential value opportunities by scanning a 52 high quality undervalued stocks that couples quality fundamentals with pricing that may look appealing.
- Spot lesser known opportunities before they hit wider radars using a screener containing 21 high quality undiscovered gems built around strong financial characteristics.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com